Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | £25.61B | £25.87B | £27.28B | £27.66B | £25.68B | £25.78B | £25.88B | £24.49B | £19.56B | £14.13B | £13.10B |
| Research & development | £358.0M | £380.0M | £408.0M | £323.0M | £304.0M | £307.0M | £376.0M | £258.0M | £191.0M | £144.0M | £60.0M |
| Operating income | £10.00B | £2.74B | −£15.75B | £10.52B | £10.23B | £9.96B | £9.02B | £9.31B | £6.41B | £4.66B | £4.56B |
| EBITDAderived | £12.24B | £5.00B | −£14.89B | £11.50B | £11.17B | £10.95B | £10.00B | £9.81B | £7.16B | £5.20B | — |
| Net income | £7.76B | £3.07B | −£14.37B | £6.67B | £6.80B | £6.40B | £5.70B | £6.03B | £37.48B | £4.65B | £4.29B |
| Basic EPSper diluted share | £3.51 | £1.37 | -£6.47 | £2.93 | £2.97 | £2.80 | £2.50 | £2.64 | £18.34 | £2.50 | £230.90 |
| Diluted EPSper diluted share | £3.49 | £1.36 | -£6.47 | £2.92 | £2.96 | £2.79 | £2.49 | £2.63 | £18.28 | £2.49 | £230.30 |